The FDA on Monday approved the first-ever GLP-1 pill from the Danish pharmaceutical giant.

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

It marks a first in this new era of weight-loss medications with Wegovy being the only so far to gain approval for a pill version of their shot.

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill

The FDA on Monday approved the first-ever GLP-1 pill from the Danish pharmaceutical giant.

La danesa se adelanta unos meses a su rival Eli Lilly, que busca luz verde para un medicamento similar